Biodesix Inc (BDSX) — Capital Reinvestment Ratio

Latest as of June 2023: 6.91x

Biodesix Inc (BDSX) has a Capital Reinvestment Ratio of 6.91x as of June 2023, meaning it reinvests 7% of its operating cash flow ($937.00K) in capital expenditures ($6.47 Million). See Biodesix Inc balance sheet quality to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

6.91x

Capex / Operating Cash Flow

Operating Cash Flow

$937.00K

USD

Capital Expenditures

$6.47 Million

USD

Data as of

Jun 2023

Most recent filing

Annual Capital Reinvestment Ratio for Biodesix Inc (None–None)

Year-by-year Capital Reinvestment Ratio for Biodesix Inc from None to None. For live market cap and broader valuation context, see BDSX stock market capitalisation.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow